Related Experiment Video
Updated: Jul 14, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Information about cancer clinical trials: an analysis of Internet resources
Craig P Carden1, Michael Jefford, Mark A Rosenthal
1Department of Clinical Haematology and Medical Oncology, Royal Melbourne Hospital, Parkville, Victoria, Australia. craig.carden@mh.org.au
Purpose:
Clinical trials are critical to improving patient outcomes, but participation in cancer clinical trials is low. Patient understanding of clinical trial process is also limited. Patients are increasingly using the Internet as a source of information. It is critical that such Internet-based information is relevant, current, balanced, and easy to access and navigate. We critically reviewed seven international online resources that provide information for patients/consumers regarding cancer clinical trials.
Methods:
Seven international websites from North America, Europe and Australia were selected based on profile/usage. Sites were evaluated with respect to their content, readability and appropriateness using a suite of standard assessment tools.
Results:
No sites performed well in terms of all assessment criteria. There was substantial variation between sites regarding information provided, content, design and readability. All sites required high literacy levels and assessment using the Standard Assessment of Means tool showed consistent deficiencies.
Conclusion:
Although there are numerous websites providing information about cancer clinical trials to patients/consumers, all evaluated sites have several shortcomings. Attention to the content of information, its presentation and the design of Internet resources has an ethical imperative, and is likely to lead to improved patient satisfaction.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Cancer Survival Analysis
Clinical Trials: Overview
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Hazard Ratio
For example, in a clinical trial evaluating a...